Withdrawal syndromes associated with antipsychotic drugs
- 1 November 1978
- journal article
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 135 (11) , 1321-1324
- https://doi.org/10.1176/ajp.135.11.1321
Abstract
Withdrawal symptoms frequently follow abrupt discontinuation of antipsychotic compounds. In addition to other somatic symptoms, withdrawal-emergent dyskinesias may be observed. "Covert dyskinesia" refers to a masked form of tardive dyskinesia that becomes clinically detectable only after antipsychotic drugs are withdrawn or their dosage is reduced. Withdrawal dyskinesia appears under similar circumstances but disappears spontaneously in 6 to 12 weeks. Cholinergic overactivity and changes in dopamine-acetylcholine balance in the basal ganglia may underlie these withdrawal syndromes. The principal value of the concept of covert dyskinesia is in the secondary and tertiary prevention of tardive dyskinesia through early discovery and treatment.Keywords
This publication has 22 references indexed in Scilit:
- Pharmacological characterization of tardive dyskinesiaPsychopharmacology, 1977
- Anti-muscarinic properties of neuroleptics and drug-induced ParkinsonismNature, 1974
- STAGES OF SCHIZOPHRENIC DECOMPENSATION AND REINTEGRATIONJournal of Nervous & Mental Disease, 1973
- Neurological consequences of psychotropic drug withdrawal in schizophrenic childrenJournal of Autism and Developmental Disorders, 1973
- Neuroleptics and Neurologic ReactionsSouthern Medical Journal, 1973
- Prolonged Drug-Induced ParkinsonismStereotactic and Functional Neurosurgery, 1973
- Withdrawal effects of phenothiazinesComprehensive Psychiatry, 1965
- Five Phenothiazine DerivativesArchives of General Psychiatry, 1961
- A Survey of Drug-Induced Extrapyramidal ReactionsJAMA, 1961
- WITHDRAWAL FROM NEUROLEPTIC DRUGSAmerican Journal of Psychiatry, 1959